Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 09:44:43 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Medical mystery: When a cough is not just a cough

focus

WSS

Vaccine advisory panel ACIP left half staffed by HHS

FDA panel signals lack of confidence in Amgen cancer drug data

The dental labor crisis is a moment of opportunity

PhRMA lawsuit over Medicare drug price negotiation tossed

Private equity deals in Medicare Advantage declines

Biogen Alzheimer’s drug launch off to slow start

leisure time

Wikipedia

entertainment

Jerome Adams on the need for new antivirals for Covid

A virus, fished out of a lake, may have saved a man’s life

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare Advantage proposed rates disappoint insurers

Anesthesiologist group: stop taking Ozempic before surgery

What to expect at HLTH 2023, the health care industry conference

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Industry veterans launch new biotech VC with $310M

Tori Bowie and the unacceptable rates of Black maternal death

FDA authorizes Novavax’s updated Covid

focus

Senate panel eyes new effort on drug shortages

KalVista pill reduced swelling 'attacks' caused by genetic disease

Colorectal cancer study finds potential in overlooked immune cell

Senators start work on Medicare physician payment reform

Why age limits for politicians are a terrible idea

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

entertainment

focus

focus

knowledge